Literature DB >> 35727883

Response by Liang and Shimada to Letter Regarding Article "Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy".

Lusha W Liang1, Yuichi J Shimada1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35727883      PMCID: PMC9228502          DOI: 10.1161/CIRCHEARTFAILURE.122.009568

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   10.447


× No keyword cloud information.
  5 in total

1.  Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.

Authors:  Roberta Roncarati; Chiara Viviani Anselmi; Maria Angela Losi; Laura Papa; Elena Cavarretta; Paula Da Costa Martins; Carla Contaldi; Gloria Saccani Jotti; Anna Franzone; Laura Galastri; Michael V G Latronico; Massimo Imbriaco; Giovanni Esposito; Leon De Windt; Sandro Betocchi; Gianluigi Condorelli
Journal:  J Am Coll Cardiol       Date:  2013-10-23       Impact factor: 24.094

2.  Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes.

Authors:  Lee Lee Wong; Ruiyang Zou; Lihan Zhou; Jia Yuen Lim; Dominic C Y Phua; Chengcheng Liu; Jenny P C Chong; Jessica Y X Ng; Oi Wah Liew; Siew Pang Chan; Yei-Tsung Chen; Michelle M Y Chan; Poh Shuan D Yeo; Tze Pin Ng; Lieng H Ling; David Sim; Kui Toh G Leong; Hean Y Ong; Fazlur Jaufeerally; Raymond Wong; Ping Chai; Adrian F Low; Mayanna Lund; Gerry Devlin; Richard Troughton; Vicky A Cameron; Robert N Doughty; Carolyn S P Lam; Heng Phon Too; Arthur Mark Richards
Journal:  J Am Coll Cardiol       Date:  2019-03-26       Impact factor: 24.094

3.  Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.

Authors:  Yuichi J Shimada; Jonathan J Passeri; Aaron L Baggish; Caitlin O'Callaghan; Patricia A Lowry; Gia Yannekis; Suhny Abbara; Brian B Ghoshhajra; Richard D Rothman; Carolyn Y Ho; James L Januzzi; Christine E Seidman; Michael A Fifer
Journal:  JACC Heart Fail       Date:  2013-10-24       Impact factor: 12.035

4.  Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy.

Authors:  Yuichi J Shimada; Yoshihiko Raita; Lusha W Liang; Mathew S Maurer; Kohei Hasegawa; Michael A Fifer; Muredach P Reilly
Journal:  Circ Heart Fail       Date:  2021-07-01       Impact factor: 10.447

5.  Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Authors:  Lu Fang; Andris H Ellims; Xiao-lei Moore; David A White; Andrew J Taylor; Jaye Chin-Dusting; Anthony M Dart
Journal:  J Transl Med       Date:  2015-09-24       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.